These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study. Hayashi M; Abe T; Iwai M; Matsui A; Yoshida T; Sato Y; Kanno Y; Clin Exp Nephrol; 2016 Oct; 20(5):787-794. PubMed ID: 26627501 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies. Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765 [TBL] [Abstract][Full Text] [Related]
32. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653 [TBL] [Abstract][Full Text] [Related]
33. Risks and complications of robot-assisted radical prostatectomy (RARP) in patients receiving antiplatelet and/or anticoagulant therapy: a retrospective cohort study in a single institute. Oshima M; Washino S; Nakamura Y; Konishi T; Saito K; Arai Y; Miyagawa T J Robot Surg; 2021 Aug; 15(4):661-670. PubMed ID: 33044699 [TBL] [Abstract][Full Text] [Related]
34. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005 [TBL] [Abstract][Full Text] [Related]
35. Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents. Uchida Y; Mori F; Ogawa H; Takagi A; Hagiwara N J Cardiol; 2010 May; 55(3):362-9. PubMed ID: 20350510 [TBL] [Abstract][Full Text] [Related]
36. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients. Abraham NS; Hartman C; Richardson P; Castillo D; Street RL; Naik AD Circulation; 2013 Oct; 128(17):1869-77. PubMed ID: 24025594 [TBL] [Abstract][Full Text] [Related]
37. Impact of the Number of Anti-Thrombosis Agents in Hemodialysis Patients: BOREAS-HD2 Study. Tanaka M; Moniwa N; Ohnishi H; Yamashita T; Koyama M; Gocho Y; Nishizawa K; Kimura Y; Sugawara H; Murakami S; Okazaki Y; Furuhashi M; Yoshida H; Miura T Kidney Blood Press Res; 2017; 42(3):553-564. PubMed ID: 28922656 [TBL] [Abstract][Full Text] [Related]
38. Assessing Bleeding Risk in Patients With Intentional Overdoses of Novel Antiplatelet and Anticoagulant Medications. Levine M; Beuhler MC; Pizon A; Cantrel FL; Spyres MB; LoVecchio F; Skolnik AB; Brooks DE Ann Emerg Med; 2018 Mar; 71(3):273-278. PubMed ID: 29032872 [TBL] [Abstract][Full Text] [Related]
39. Dual antiplatelet and oral anticoagulant therapy: increasing use and precautions for a hazardous combination. Hylek EM; Solarz DE JACC Cardiovasc Interv; 2008 Feb; 1(1):62-4. PubMed ID: 19393146 [No Abstract] [Full Text] [Related]
40. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. Chan KE; Lazarus JM; Thadhani R; Hakim RM J Am Soc Nephrol; 2009 Apr; 20(4):872-81. PubMed ID: 19297555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]